The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine
Abstract
Mesenchymal stem cells (MSCs), which can be obtained from various organs and easily propagated in vitro, are one of the most extensively used types of stem cells and have been shown to be efficacious in a broad set of diseases. The unique and highly desirable properties of MSCs include high migratory capacities toward injured areas, immunomodulatory features, and the natural ability to differentiate into connective tissue phenotypes. These phenotypes include bone and cartilage, and these properties predispose MSCs to be therapeutically useful. In addition, MSCs elicit their therapeutic effects by paracrine actions, in which the metabolism of target tissues is modulated. Genetic engineering methods can greatly amplify these properties and broaden the therapeutic capabilities of MSCs, including transdifferentiation toward diverse cell lineages. However, cell engineering can also affect safety and increase the cost of therapy based on MSCs; thus, the advantages and disadvantages of these procedures should be discussed. In this review, the latest applications of genetic engineering methods for MSCs with regenerative medicine purposes are presented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, MSCs were already shown to be capable of expressing a wide range of neuroregulatory molecules that regulate NSCs fate, axon guidance, neural cell adhesion, neurite growth factors, neurotransmitter receptors, and neurotrophic factors [223].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [223]
Citations
Cites
Akiyama, H., Chaboissier, M.-C., Martin, J. F., Schedl, A., & de Crombrugghe, B. (2002) · Genes & Development · doi:10.1101/gad.1017802 · Cited by 1,721
Retinoic acid from the meninges regulates cortical neuron generation.
Siegenthaler, J. A., Ashique, A. M., Zarbalis, K., Patterson, K. P., Hecht, J. H., Kane, M. A., Folias, A. E., Choe, Y., May, S. R., Kume, T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.004 · Cited by 402
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380
Kapsimali, M., Kloosterman, W. P., de Bruijn, E., Rosa, F., Plasterk, R. H., & Wilson, S. W. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r173 · Cited by 376
Wang, D., Luo, P., Wang, Y., Li, W., Wang, C., Sun, D., Zhang, R., Su, T., Ma, X., Zeng, C., et al. (2013) · Diabetes · doi:10.2337/db12-1025 · Cited by 179
Flagged first, then by citations
Research works printed but not linked: 289
- 10.3727/096368914X678436 · DOI
- 10.4252/wjsc.v6.i2.120 · DOI
- 10.1016/j.ejca.2014.02.011 · DOI
- 10.1126/science.284.5411.143 · DOI · Paper page
- 10.3389/fimmu.2013.00201 · DOI
- 10.1038/nm.3219 · DOI
- 10.1007/s00167-012-2329-3 · DOI
- 10.1089/wound.2012.0420 · DOI
- 10.1002/pmic.201000402 · DOI
- 10.1515/hsz-2013-0107 · DOI
- 10.1016/S0254-6272(12)60038-7 · DOI
- 10.1089/ten.tec.2011.0413 · DOI
- 10.1007/s11596-012-1025-3 · DOI
- 10.4238/2014.February.20.8 · DOI
- 10.3760/cma.j.issn.0366-6999.20132337 · DOI
- 10.1016/j.biomaterials.2013.11.019 · DOI
- 10.1111/cbdd.12398 · DOI
- 10.1016/j.biomaterials.2012.09.069 · DOI
- 10.1177/0300060513501123 · DOI
- 10.4103/1673-5374.125327 · DOI
- 10.3389/fnagi.2014.00030 · DOI
- 10.1155/2014/129145 · DOI
- 10.1016/j.jpedsurg.2010.09.040 · DOI · Paper page
- 10.1182/blood-2013-04-495119 · DOI
- 10.1038/mtm.2014.41 · DOI
- 10.1016/j.jcyt.2013.02.009 · DOI
- 10.1016/j.jpedsurg.2014.01.030 · DOI
- 10.1007/s10616-011-9413-2 · DOI
- 10.1371/journal.pone.0092420 · DOI
- 10.1016/j.jconrel.2010.07.124 · DOI
- 10.1002/jor.22884 · DOI
- 10.1007/s11999-012-2475-4 · DOI
- 10.55782/ane-2013-1918 · DOI
- 10.1089/scd.2014.0521 · DOI
- 10.1074/jbc.M114.605063 · DOI
- 10.1016/j.bbrc.2010.10.013 · DOI
- 10.1096/fj.14-254169 · DOI
- 10.1002/term.435 · DOI
- 10.1016/j.cyto.2014.08.005 · DOI
- 10.1093/eurjhf/hfp135 · DOI
- 10.1016/j.ijcard.2005.07.061 · DOI
- 10.1016/j.jcyt.2013.10.014 · DOI
- 10.1016/j.bbrc.2013.09.053 · DOI
- 10.1161/ATVBAHA.113.301217 · DOI
- 10.1038/ncomms5552 · DOI
- 10.1007/s10456-010-9169-x · DOI
- 10.1007/s10529-011-0654-0 · DOI
- Hua J, , He ZG, , Qian DH, , Lin SP, , Gong J, , Meng HB, , Yang TS, , Sun W, , Xu B, , Zhou B, and Song ZS. (2014). Angiopoietin-1 gene-modified human mesenchymal stem cells promote angiogenesis and reduce acute pancreatitis in rats. Int J Clin Exp Pathol, 7:3580–3595.
- 10.1016/j.jcyt.2013.02.014 · DOI
- 10.1007/s11596-013-1151-6 · DOI
- 10.1590/1414-431X20143765 · DOI
- 10.1089/rej.2012.1325 · DOI
- 10.1186/1479-5876-11-81 · DOI
- 10.1186/1423-0127-17-80 · DOI
- 10.1152/ajpheart.00557.2010 · DOI
- 10.1089/biores.2012.9905 · DOI
- 10.1002/stem.1682 · DOI
- 10.1016/j.devcel.2008.07.008 · DOI · Paper page
- 10.5603/CJ.2011.0032 · DOI
- 10.3892/ijmm.2012.1200 · DOI
- 10.1002/jcp.24794 · DOI
- 10.1007/s11906-014-0431-2 · DOI
- 10.1155/2012/147825 · DOI
- 10.1152/ajpendo.00022.2008 · DOI
- 10.1186/1476-511X-13-53 · DOI
- 10.1177/2041731412462018 · DOI
- 10.1002/iub.322 · DOI
- 10.1016/j.tice.2012.04.002 · DOI
- 10.1038/gt.2011.139 · DOI
- 10.1179/1607845413Y.0000000093 · DOI
- 10.1089/scd.2012.0638 · DOI
- 10.1007/s11033-014-3351-y · DOI
- 10.1006/excr.1997.3858 · DOI
- 10.1016/j.injury.2012.09.024 · DOI
- 10.4067/S0716-97602013000400015 · DOI
- 10.1016/j.actbio.2013.07.023 · DOI
- 10.1074/jbc.M305312200 · DOI
- Deng WW, , Cao X, , Wang M, , Qu R, , Su WY, , Yang Y, , Wei YW, , Xu XM, and Yu JN. (2012). Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles. Int J Nanomedicine, 7:1297–1311.
- 10.3892/etm.2012.765 · DOI
- 10.1016/j.bbrc.2014.07.045 · DOI
- 10.1007/s11596-013-1182-z · DOI
- 10.1155/2014/816979 · DOI
- 10.4238/2014.January.17.14 · DOI
- 10.1016/j.tice.2011.11.005 · DOI
- 10.1007/s10439-009-9892-x · DOI
- 10.4238/2014.June.16.4 · DOI
- 10.1016/j.bbrc.2006.02.052 · DOI
- 10.1007/s11517-010-0729-4 · DOI
- 10.1186/scrt491 · DOI
- 10.1186/ar4260 · DOI
- 10.1007/s11010-014-1963-0 · DOI
- 10.1016/j.biomaterials.2010.08.086 · DOI
- 10.1016/j.biomaterials.2012.02.051 · DOI
- 10.1186/scrt113 · DOI
- 10.1159/000127448 · DOI
- 10.1002/art.30430 · DOI
- 10.1089/scd.2010.0516 · DOI
- 10.1016/j.biomaterials.2011.01.063 · DOI
- 10.1016/j.biomaterials.2011.06.059 · DOI
- 10.1016/j.bbrc.2013.01.127 · DOI
- 10.1155/2013/326828 · DOI
- 10.1089/scd.2012.0282 · DOI
- 10.1097/01.brs.0000248428.22823.86 · DOI
- 10.1016/j.spinee.2012.02.027 · DOI
- 10.1097/BRS.0000000000000316 · DOI
- 10.1016/j.jconrel.2014.05.053 · DOI
- 10.1002/jor.21144 · DOI
- 10.3892/etm.2013.1162 · DOI
- Jin H, , Zhang K, , Qiao C, , Yuan A, , Li D, , Zhao L, , Shi C, , Xu X, , Ni S, et al. (2014). Efficiently engineered cell sheet using a complex of polyethylenimine-alginate nanocomposites plus bone morphogenetic protein 2 gene to promote new bone formation. Int J Nanomedicine, 9:2179–2190.
- 10.4103/0019-5413.136208 · DOI
- 10.1016/j.biomaterials.2013.05.048 · DOI
- 10.1089/ten.tea.2012.0085 · DOI
- 10.3892/mmr.2012.1237 · DOI
- 10.1111/j.1365-2184.2011.00747.x · DOI
- 10.1088/1748-6041/6/1/015013 · DOI
- 10.3892/etm.2013.1464 · DOI
- 10.1016/j.tice.2014.06.001 · DOI
- Liu B, , Li X, , Liang G, and Liu X. (2011). VEGF expression in mesenchymal stem cells promotes bone formation of tissue-engineered bones. Mol Med Rep, 4:1121–1126.
- 10.1159/000337490 · DOI
- 10.1007/s12013-014-0042-1 · DOI
- 10.1016/j.bone.2011.08.004 · DOI
- 10.1371/journal.pone.0010853 · DOI
- 10.1371/journal.pone.0060473 · DOI
- 10.3892/mmr.2012.1090 · DOI
- 10.1038/gt.2012.45 · DOI
- An G, , Xue Z, , Zhang B, , Deng QK, , Wang YS, and Lv SC. (2014). Expressing osteogenic growth peptide in the rabbit bone mesenchymal stem cells increased alkaline phosphatase activity and enhanced the collagen accumulation. Eur Rev Med Pharmacol Sci, 18:1618–1624.
- 10.1002/stem.697 · DOI
- 10.11005/jbm.2014.21.1.41 · DOI
- 10.1016/j.regpep.2010.04.006 · DOI
- 10.1016/j.biomaterials.2013.10.021 · DOI
- 10.1016/j.jconrel.2012.11.013 · DOI
- Hu HM, , Yang L, , Wang Z, , Liu YW, , Fan JZ, , Fan J, , Liu J, and Luo ZJ. (2013). Overexpression of integrin a2 promotes osteogenic differentiation of hBMSCs from senile osteoporosis through the ERK pathway. Int J Clin Exp Pathol, 6:841–852.
- 10.1093/abbs/gms070 · DOI
- 10.1002/jcp.24500 · DOI
- Li ZH, , Liao W, , Zhao Q, , Huan T, , Feng P, , Wei X, , Yi Y, and Shao NS. (2014). Effect of Cbfa1 on osteogenic differentiation of mesenchymal stem cells under hypoxia condition. Int J Clin Exp Med, 7:540–548.
- Suh JS, , Lee JY, , Choi YJ, , You HK, , Hong SD, , Chung CP, and Park YJ. (2014). Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis. Int J Nanomedicine, 9:1153–1166.
- 10.1007/s11010-013-1851-z · DOI
- 10.1002/jcp.24116 · DOI
- 10.1074/jbc.M809787200 · DOI
- 10.1016/j.biomaterials.2013.02.039 · DOI
- 10.1016/j.biomaterials.2014.02.055 · DOI
- 10.22203/eCM.v027a02 · DOI
- 10.1007/s10616-012-9439-0 · DOI
- 10.1096/fasebj.10.2.8641560 · DOI
- 10.1016/j.cbi.2011.01.009 · DOI
- 10.1371/journal.pone.0104133 · DOI
- 10.1111/j.1440-1746.2012.07137.x · DOI
- 10.1007/s13105-014-0346-z · DOI
- 10.1111/liv.12239 · DOI
- 10.1002/jcb.24822 · DOI
- 10.1038/cddis.2013.429 · DOI
- 10.1371/journal.pone.0044737 · DOI
- 10.1016/j.devcel.2014.04.033 · DOI
- 10.1016/j.bbrc.2010.03.158 · DOI
- 10.5966/sctm.2012-0027 · DOI
- 10.3892/mmr.2014.2812 · DOI
- 10.7150/thno.7729 · DOI
- 10.5966/sctm.2012-0064 · DOI
- 10.1016/j.gene.2008.12.008 · DOI
- 10.1073/pnas.0702859104 · DOI
- 10.1007/s10616-013-9605-z · DOI
- 10.1089/scd.2010.0380 · DOI
- 10.1073/pnas.61.2.748 · DOI · Paper page
- 10.1016/j.lfs.2012.08.014 · DOI
- 10.1152/ajpheart.01330.2008 · DOI
- 10.1002/stem.1687 · DOI
- 10.1172/JCI63635 · DOI
- 10.1161/CIRCRESAHA.113.301690 · DOI
- 10.1016/j.semcdb.2004.10.003 · DOI
- 10.3109/14653249.2011.597380 · DOI
- 10.1016/j.bbagen.2014.02.020 · DOI
- 10.1016/j.biocel.2013.09.007 · DOI
- 10.1371/journal.pone.0073304 · DOI
- 10.1186/1476-4598-9-229 · DOI
- 10.1002/stem.1154 · DOI
- 10.1016/j.bbrc.2012.03.092 · DOI
- 10.1161/ATVBAHA.109.197434 · DOI
- 10.1038/ng1725 · DOI
- 10.1007/s00109-012-0920-1 · DOI
- 10.3892/mmr.2013.1431 · DOI
- 10.1152/physrev.00029.2008 · DOI
- 10.1046/j.1432-1327.2001.02036.x · DOI
- 10.1111/pace.12154 · DOI
- 10.1016/j.jcyt.2013.03.010 · DOI
- 10.1002/jcp.24480 · DOI
- 10.1007/s11033-012-1867-6 · DOI
- 10.1371/journal.pone.0022924 · DOI
- 10.1016/j.expneurol.2005.10.029 · DOI
- 10.1016/j.jstrokecerebrovasdis.2014.05.032 · DOI
- Huang P, , Gebhart N, , Richelson E, , Brott TG, , Meschia JF, and Zubair AC. (2014). Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation. Cytotherapy, pii:S1465-3249(14)00605-7.
- 10.1186/1742-2094-10-106 · DOI
- 10.1002/cbin.10029 · DOI
- 10.1016/j.jcyt.2014.02.003 · DOI
- Hedayatpour A, , Ragerdi I, , Pasbakhsh P, , Kafami L, , Atlasi N, , Pirhajati Mahabadi V, , Ghasemi S, and Reza M. (2013). Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis. Cell J, 15:142–151.
- 10.4103/1673-5374.131596 · DOI
- 10.1186/scrt341 · DOI
- 10.1016/j.nbd.2013.10.014 · DOI
- 10.1007/s12031-012-9908-0 · DOI
- 10.1196/annals.1403.009 · DOI · Paper page
- 10.1016/j.biomaterials.2013.12.021 · DOI
200 of 289 shown
Cited by
Sorted by citations
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“Indeed, MSCs were already shown to be capable of expressing a wide range of neu-roregulatory molecules that regulate NSCs fate, axon guidance, neural cell adhesion, neurite growth factors, neurotransmitter receptors, and neurotrophic factors [223].”
Han, S. H., Cha, M., Jin, Y.-Z., Lee, K.-M., & Lee, J. H. (2021) · Biomedical Materials · doi:10.1088/1748-605x/aba879 · Cited by 53
Metadata
- Authors
- Nowakowski, A., Walczak, P., Janowski, M., & Lukomska, B.
- Affiliations
- Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
- Johns Hopkins University (US)
- Polish Academy of Sciences
- Corresponding author
- Nowakowski, Adam
- Venue
- Stem Cells and Development
- Publisher
- SAGE Publications
- Published
- 2015-07-03
- Volume
- 24
- Issue
- 19
- Pages
- 2219-2242
- ISSN
- 1525-8165 (ISSN-L)
- 1547-3287
- 1557-8534
- OpenAlex
- W1944852218
- Cited by
- 38
- References
- 5
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 8 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 7
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Stem Cells and Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Narodowe Centrum Badań i Rozwoju
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Keywords
- mesenchymal stem cells, genetic engineering, regenerative medicine, transdifferentiation, immunomodulation, paracrine signaling, cell therapy safety
- MeSH terms
- Cell Differentiation, Genetic Engineering, Humans, Cytokines, Outcome Assessment, Health Care, Inflammation Mediators, Transgenes, Tissue Engineering, Regenerative Medicine, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review